UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000005366
Receipt No. R000006291
Scientific Title A phase II study of trastuzumab added to docetaxel and S-1 for human epidermal growth factor receptor 2 (HER2)-positive advanced gastric cancer.
Date of disclosure of the study information 2011/04/26
Last modified on 2018/01/04 09:50:45

No. Disposal Last modified on Item of update
1 Insert 2011/04/01 21:15:07
2 Update 2011/04/19 16:22:54 Public title
Acronym
3 Update 2011/04/19 16:24:04 Acronym
4 Update 2011/06/07 14:16:17 Recruitment status
5 Update 2012/10/01 11:29:46 Post marketing survey by drug manufacture etc., specified by Japanese law.
6 Update 2013/10/01 20:35:52 Email
7 Update 2017/10/05 14:29:31 Name of primary sponsor
Organization
Organization
8 Update 2017/10/05 14:31:19 Recruitment status
Last follow-up date
9 Update 2018/01/04 09:50:45 Recruitment status
Date analysis concluded
Publication of results
URL related to results and publications


Contact us.